AI Generated Image
Student, 19, Dies After Taking Drug Used by Millions of Americans
The Daily Beast • • health
Key Points:
- Josephine Nasr, a 19-year-old law student from California, died in her London dorm after taking the GLP-1 weight loss drug tirzepatide, sold under brand names Mounjaro and Zepbound.
- Nasr experienced nausea and vomiting, known side effects of GLP-1 drugs, before being found unresponsive on the bathroom floor with an empty vial of the medication nearby.
- A coroner ruled the cause of death as cardiac arrhythmia, linked to a congenital heart condition called myocardial bridging, with vomiting and low blood sugar from the drug potentially triggering the fatal heart rhythm.
- Nasr was prescribed Zepbound despite not being obese, having a BMI categorized as overweight, and her death has raised concerns about the safety of weight loss medications in young, otherwise healthy individuals.
- Family members described Nasr as joyful and caring, and her death has deeply affected them, highlighting the need for caution and medical supervision when using appetite-suppressing drugs.
